[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 55, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 674000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 54, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.32, "open": 7.32, "dayLow": 7.29, "dayHigh": 7.67, "regularMarketPreviousClose": 7.32, "regularMarketOpen": 7.32, "regularMarketDayLow": 7.29, "regularMarketDayHigh": 7.67, "exDividendDate": 1742169600, "payoutRatio": 0.0, "beta": 0.211, "trailingPE": 29.64, "forwardPE": 23.903225, "volume": 266140, "regularMarketVolume": 266140, "averageVolume": 202353, "averageVolume10days": 181720, "averageDailyVolume10Day": 181720, "bid": 5.52, "ask": 9.44, "bidSize": 2, "askSize": 2, "marketCap": 426112032, "fiftyTwoWeekLow": 4.74, "fiftyTwoWeekHigh": 9.15, "priceToSalesTrailing12Months": 2.6474316, "fiftyDayAverage": 7.0466, "twoHundredDayAverage": 5.9121, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 400723712, "profitMargins": 0.08984999, "floatShares": 10077661, "sharesOutstanding": 57505000, "sharesShort": 166072, "sharesShortPriorMonth": 42566, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0029, "heldPercentInsiders": 0.07218, "heldPercentInstitutions": 0.50011003, "shortRatio": 0.56, "shortPercentOfFloat": 0.0053, "impliedSharesOutstanding": 57947300, "bookValue": 4.107, "priceToBook": 1.8042367, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.247, "netIncomeToCommon": 14462000, "trailingEps": 0.25, "forwardEps": 0.31, "enterpriseToRevenue": 2.49, "enterpriseToEbitda": 11.835, "52WeekChange": 0.2977233, "SandP52WeekChange": 0.12744582, "lastDividendValue": 0.006, "lastDividendDate": 1371081600, "quoteType": "EQUITY", "currentPrice": 7.41, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.25, "targetMedianPrice": 13.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 78435000, "totalCashPerShare": 1.242, "ebitda": 33859000, "totalDebt": 11062000, "quickRatio": 2.137, "currentRatio": 3.733, "totalRevenue": 160952992, "debtToEquity": 4.263, "revenuePerShare": 2.782, "returnOnAssets": 0.03447, "returnOnEquity": 0.05745, "grossProfits": 69967000, "freeCashflow": 24019376, "operatingCashflow": 47594000, "earningsGrowth": -0.298, "revenueGrowth": 0.071, "grossMargins": 0.4347, "ebitdaMargins": 0.21037, "operatingMargins": 0.13019, "financialCurrency": "USD", "symbol": "KMDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 3.91363, "postMarketPrice": 7.7, "postMarketChange": 0.29, "regularMarketChange": 0.089999676, "regularMarketDayRange": "7.29 - 7.67", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 202353, "fiftyTwoWeekLowChange": 2.67, "fiftyTwoWeekLowChangePercent": 0.5632912, "fiftyTwoWeekRange": "4.74 - 9.15", "fiftyTwoWeekHighChange": -1.7399998, "fiftyTwoWeekHighChangePercent": -0.19016391, "fiftyTwoWeekChangePercent": 29.77233, "earningsTimestamp": 1741176300, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1741179600, "earningsCallTimestampEnd": 1741179600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.25, "epsForward": 0.31, "epsCurrentYear": 0.29, "priceEpsCurrentYear": 25.551723, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "Kamada Ltd.", "corporateActions": [{"header": "Dividend", "message": "KMDA announced a cash dividend of 0.20 with an ex-date of Mar. 17, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1742187600000, "amount": "0.20"}}], "postMarketTime": 1741394636, "regularMarketTime": 1741381201, "exchange": "NMS", "messageBoardId": "finmb_9002466", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.2295038, "regularMarketPrice": 7.41, "marketState": "CLOSED", "longName": "Kamada Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1370007000000, "fiftyDayAverageChange": 0.36339998, "fiftyDayAverageChangePercent": 0.05157097, "twoHundredDayAverageChange": 1.4979, "twoHundredDayAverageChangePercent": 0.25336176, "displayName": "Kamada", "trailingPegRatio": 1.0879, "__fetch_time": "2025-03-08"}]